Page 1 | Search Results | Blood | American Society of Hematology

1-20 of 35

Sort by

Sort Order Select

Journal Articles

Ritonavir- and lopinavir-induced eryptosis in a SARS-CoV-2–infected patient

Gregoire Stalder, Lorenzo Alberio

Blood (2020) 136 (7): 915.

https://doi.org/10.1182/blood.2020006228

Published: 2020

Journal Articles

Safety and Efficacy of Brentuximab Vedotin in Combination with AVD in Stage II-IV HIV-Associated Classical Hodgkin Lymphoma: Results of the Phase 2 Study, AMC 085

Blood (2019) 134 (Supplement_1): 130.

https://doi.org/10.1182/blood-2019-126787

Published: 2019

Journal Articles

Differential Effects of HIV Protease Inhibitors on Release and Activation of Platelet-Derived TGF-β1: Potential Association with HIV-Linked CVD

Kouzbari Karim, DDS, Gostynska Sandra, MS, Sonia Elhadad, PhD, Dube Pratibha, MS, Jeffrey Laurence, MD, Jasimuddin Ahamed, PhD

Blood (2019) 134 (Supplement_1): 2341.

https://doi.org/10.1182/blood-2019-126225

Published: 2019

Journal Articles

Phase I Trial Results of a Solid Dispersion Formulation of Deferasirox with Enhanced Bioavailability Relative to Exjade ® and Jadenu TM

Justin Keen, PhD, Dave Miller, PhD, Simon Tulloch, BA MA BM BCh

Blood (2017) 130 (Supplement 1): 2215.

https://doi.org/10.1182/blood.V130.Suppl_1.2215.2215

Published: 2017

Journal Articles

5-Azacytidine Prevents Relapse from Discrete Bone Marrow Sites in Leukemia Xenografts Treated with CD22-Targeting Immunotoxin Moxetumomab Pasudotox

Fabian Mueller, MD, Tyler Cunningham, Stephanie Stookey, Chin-Hsien Tai, Alan S. Wayne, MD, Ira Pastan, MD

Blood (2016) 128 (22): 2810.

https://doi.org/10.1182/blood.V128.22.2810.2810

Published: 2016

Journal Articles

Anti-Lymphoma Activity of Interferon-Free Antiviral Treatment in Patients with Indolent B-Cell Lymphomas Associated with Hepatitis C Virus Infection

Luca Arcaini, Caroline Besson, Jan Peveling-Oberhag, MD, Véronique Loustaud-Ratti, MD PhD, Sara Rattotti, Virginia Ferretti, PhD, Anna Linda Zignego, MD PhD, Milvia Casato, MD PhD, Michele Merli, MD, Olivier Hermine, Carlo Visco, MD

Blood (2015) 126 (23): 3938.

https://doi.org/10.1182/blood.V126.23.3938.3938

Published: 2015

Journal Articles

AMC-085: A Pilot Trial of AVD and Brentuximab Vedotin in the Upfront Treatment of Stage II-IV HIV-Associated Hodgkin Lymphoma. A Trial of the AIDS Malignancy Consortium

Paul G. Rubinstein, MD, Page Moore, PhD, David H. Henry, MD, Lee Ratner, MD PhD, Elad Sharon, MD MPH, Ariela Noy, MD

Blood (2015) 126 (23): 1526.

https://doi.org/10.1182/blood.V126.23.1526.1526

Published: 2015

Journal Articles

Initial Experience with Thrombopoetin Receptor Agonists (TRA) in 5 Patients with Refractory HIV-Associated Immune Thrombocytopenic Purpura (ITP)

Mark Kowalczyk, Paul G. Rubinstein, MD, David M Aboulafia, MD

Blood (2014) 124 (21): 5014.

https://doi.org/10.1182/blood.V124.21.5014.5014

Published: 2014

Journal Articles

Targeting Glycolysis and Compensatory Mitochondrial Metabolism In An In Vivo Xenograft Model Of Multiple Myeloma With FDA Approved Ritonavir and Metformin

Sevim Dalva-Aydemir, MS, Kehinde U.A. Adekola, MBBS, Jennifer Koblinski, PhD, Noopur Raje, MD, Steven T. Rosen, MD, FRCPA, Mala Shanmugam, PhD

Blood (2013) 122 (21): 1922.

https://doi.org/10.1182/blood.V122.21.1922.1922

Published: 2013

Journal Articles

Targeting Glycolysis and Compensatory Mitochondrial Metabolism in Multiple Myeloma with FDA Approved Ritonavir and Metformin Via Synthetic Lethality

Kehinde U. A. Adekola, M.B.B.S, Maylyn Martinez, Steven T. Rosen, MD, FRCPA, Mala Shanmugam, PhD

Blood (2012) 120 (21): 4016.

https://doi.org/10.1182/blood.V120.21.4016.4016

Published: 2012

Journal Articles

Modulation of Proinflammatory Cytokines and Insulinlike Growth Factor-1 (IGF-1) in Human Immunodeficiency Virus-1 Smoldering Multiple Myeloma (HIVSMM) Patients

Eugene McPherson, MD, PhD, Philippe Tassy, MD

Blood (2012) 120 (21): 5043.

https://doi.org/10.1182/blood.V120.21.5043.5043

Published: 2012

Journal Articles

Multiple myeloma exhibits novel dependence on GLUT4, GLUT8, and GLUT11: implications for glucose transporter-directed therapy

Samuel K. McBrayer, Javelin C. Cheng, Seema Singhal, Nancy L. Krett, Steven T. Rosen, Mala Shanmugam

Blood (2012) 119 (20): 4686–4697.

https://doi.org/10.1182/blood-2011-09-377846

Published: 2012

Includes: Supplemental data

Journal Articles

Chemotherapy Toxicity Occurrence with Concomitant Antiretroviral Therapy in Patients with Lymphoma,

James M Mikula, Pharm.D., Lynn Weber, Pharm.D, BCOP, Katie Won, Pharm.D, BCOP

Blood (2011) 118 (21): 4210.

https://doi.org/10.1182/blood.V118.21.4210.4210

Published: 2011

Journal Articles

Myeloma Exhibits Dependence on Atypical Glucose Transporters: Targeting MCL-1 Through GLUT4 Inhibition

Mala Shanmugam, PhD, Javelin C Cheng, MS, Samuel K McBrayer, Steven T. Rosen, MD, FRCPA

Blood (2011) 118 (21): 1850.

https://doi.org/10.1182/blood.V118.21.1850.1850

Published: 2011

Journal Articles

Efficacy of Intrathecal Rituximab In the Management of CNS Relapse of Aggressive HIV Related Lymphoma

Suthanthira Kannan Ramamoorthy, MD, FRCPA, Vishnu Kumar, R Scientist, Jr.

Blood (2010) 116 (21): 4929.

https://doi.org/10.1182/blood.V116.21.4929.4929

Published: 2010

Journal Articles

The HIV Protease Inhibitor Nelfinavir: A Unique Oral Drug That Inhibits the Proteasome and AKT-Phosphorylation, Induces ER Stress and Sensitizes Bortezomib-Refractory Primary Myeloma Cells and Primary AML Cells towards Bortezomib

Christoph Driessen, MD, Jürgen Bader, Marianne Kraus

Blood (2010) 116 (21): 4069.

https://doi.org/10.1182/blood.V116.21.4069.4069

Published: 2010

Journal Articles

Ritonavir Based Highly Active Retroviral Therapy (HAART) Correlates with Early Neurotoxicity When Combined with ABVD Treated HIV Associated Hodgkin Lymphoma but Not Non-Hodgkin Lymphoma. A Retrospective Study.

Paul G. Rubinstein, MD, Tareq Braik, MD, Shivi Jain, MD, Jennifer Orsi, MPH, Shweta Gupta, MD, Gail Itokazu, PharmD, Margaret Telfer, MD, Muhammed Irfan, MD, Audrey French, MD

Blood (2010) 116 (21): 2807.

https://doi.org/10.1182/blood.V116.21.2807.2807

Published: 2010

Journal Articles

Targeting the PI3K/AKT/Survivin Pathway with Ritonavir In Therapy-Resistant Mantle Cell Lymphoma

Tara M Nordgren,, BS, Ganapati Hegde, PhD, Corey Munger, PhD, Julie M. Vose, MD, Shantaram Joshi, PhD

Blood (2010) 116 (21): 2855.

https://doi.org/10.1182/blood.V116.21.2855.2855

Published: 2010

Journal Articles

Modulation of Soluble Interleukin 2 Receptor (sIL-2R) Levels in Patients with HIVWaldenstrom Macroglobulinemia (HIV-WM) Treated with Biaxin-Pentoxifylline-Dexamethasone Followed by Prednisolone (BPD-Pred)

Eugene McPherson, MD, PhD, P. Tassy, MD

Blood (2008) 112 (11): 5214.

https://doi.org/10.1182/blood.V112.11.5214.5214

Published: 2008

Journal Articles

Inhibition of Autophagy Promotes Bortezomib-Mediated Cell Death in Myeloma Cells

Terry H. Landowski, PhD, Aluvia M Escalante, Andrew Jefferson, Robert T Dorr, Ronald Lynch

Blood (2008) 112 (11): 3677.

https://doi.org/10.1182/blood.V112.11.3677.3677

Published: 2008

NARROW

Ritonavir- and lopinavir-induced eryptosis in a SARS-CoV-2–infected patient

Safety and Efficacy of Brentuximab Vedotin in Combination with AVD in Stage II-IV HIV-Associated Classical Hodgkin Lymphoma: Results of the Phase 2 Study, AMC 085

Differential Effects of HIV Protease Inhibitors on Release and Activation of Platelet-Derived TGF-β1: Potential Association with HIV-Linked CVD

Phase I Trial Results of a Solid Dispersion Formulation of Deferasirox with Enhanced Bioavailability Relative to Exjade ® and Jadenu TM

5-Azacytidine Prevents Relapse from Discrete Bone Marrow Sites in Leukemia Xenografts Treated with CD22-Targeting Immunotoxin Moxetumomab Pasudotox

Anti-Lymphoma Activity of Interferon-Free Antiviral Treatment in Patients with Indolent B-Cell Lymphomas Associated with Hepatitis C Virus Infection

AMC-085: A Pilot Trial of AVD and Brentuximab Vedotin in the Upfront Treatment of Stage II-IV HIV-Associated Hodgkin Lymphoma. A Trial of the AIDS Malignancy Consortium

Initial Experience with Thrombopoetin Receptor Agonists (TRA) in 5 Patients with Refractory HIV-Associated Immune Thrombocytopenic Purpura (ITP)

Targeting Glycolysis and Compensatory Mitochondrial Metabolism In An In Vivo Xenograft Model Of Multiple Myeloma With FDA Approved Ritonavir and Metformin

Targeting Glycolysis and Compensatory Mitochondrial Metabolism in Multiple Myeloma with FDA Approved Ritonavir and Metformin Via Synthetic Lethality

Modulation of Proinflammatory Cytokines and Insulinlike Growth Factor-1 (IGF-1) in Human Immunodeficiency Virus-1 Smoldering Multiple Myeloma (HIVSMM) Patients

Multiple myeloma exhibits novel dependence on GLUT4, GLUT8, and GLUT11: implications for glucose transporter-directed therapy

Chemotherapy Toxicity Occurrence with Concomitant Antiretroviral Therapy in Patients with Lymphoma,

Myeloma Exhibits Dependence on Atypical Glucose Transporters: Targeting MCL-1 Through GLUT4 Inhibition

Efficacy of Intrathecal Rituximab In the Management of CNS Relapse of Aggressive HIV Related Lymphoma

The HIV Protease Inhibitor Nelfinavir: A Unique Oral Drug That Inhibits the Proteasome and AKT-Phosphorylation, Induces ER Stress and Sensitizes Bortezomib-Refractory Primary Myeloma Cells and Primary AML Cells towards Bortezomib

Ritonavir Based Highly Active Retroviral Therapy (HAART) Correlates with Early Neurotoxicity When Combined with ABVD Treated HIV Associated Hodgkin Lymphoma but Not Non-Hodgkin Lymphoma. A Retrospective Study.

Targeting the PI3K/AKT/Survivin Pathway with Ritonavir In Therapy-Resistant Mantle Cell Lymphoma

Modulation of Soluble Interleukin 2 Receptor (sIL-2R) Levels in Patients with HIVWaldenstrom Macroglobulinemia (HIV-WM) Treated with Biaxin-Pentoxifylline-Dexamethasone Followed by Prednisolone (BPD-Pred)

Inhibition of Autophagy Promotes Bortezomib-Mediated Cell Death in Myeloma Cells

Email alerts

ASH Publications

American Society of Hematology

Email alerts

ASH Publications

American Society of Hematology

This Feature Is Available To Subscribers Only